Nishihara, S., Koseki, M., Tanaka, K., Omatsu, T., Saga, A., Sawabe, H., . . . Sakata, Y. Tofogliflozin attenuates renal lipid deposition and inflammation via PPARα upregulation mediated by miR-21a impairment in diet-induced steatohepatitic mice. The Japan Endocrine Society.
Chicago Style (17th ed.) CitationNishihara, Sae, et al. Tofogliflozin Attenuates Renal Lipid Deposition and Inflammation via PPARα Upregulation Mediated by MiR-21a Impairment in Diet-induced Steatohepatitic Mice. The Japan Endocrine Society.
MLA (9th ed.) CitationNishihara, Sae, et al. Tofogliflozin Attenuates Renal Lipid Deposition and Inflammation via PPARα Upregulation Mediated by MiR-21a Impairment in Diet-induced Steatohepatitic Mice. The Japan Endocrine Society.
Warning: These citations may not always be 100% accurate.